Byrns P J
Division of Drugs and Technology Standards, American Medical Association, Chicago, Illinois 80611, USA.
Clin Ther. 1998;20 Suppl C:C118-23. doi: 10.1016/s0149-2918(98)80016-7.
Changes in a drug's availability from prescription only to over-the-counter (OTC) status is of concern to physicians from both public health and individual patient perspectives. While acknowledging the potential benefits of these switches, the author notes important caveats, including the need for scientifically derived pediatric dosages; information in the medical record regarding OTC use that allows cohesive monitoring; clarity and precision in labeling for consumers; and continued coverage of such drugs for medically indigent patient populations. Current actions by physician organizations are noted.
从仅凭处方用药改为非处方(OTC)用药,这一药物可及性的变化从公共卫生和个体患者的角度来看都受到医生的关注。在承认这些转变可能带来益处的同时,作者指出了一些重要的注意事项,包括需要有科学推导得出的儿科剂量;病历中有关非处方用药的信息以便进行连贯的监测;面向消费者的标签要清晰准确;以及继续为医疗贫困患者群体提供此类药物的覆盖范围。文中还提到了医师组织目前的行动。